Vitale Albert T

Shantha Jessica G, Moussa Kareem, Laovirojjanakul Wipada, Yeh Steven, Tsui Edmund, Chen Judy L et al.

This study found metagenomic sequencing access for intraocular infections modestly improved clinical outcomes in a subset of patients, suggesting its potential to guide treatment.

Gonzales John, Acharya Nisha R, Sugar Elizabeth A, Burke Alyce E, Vitale Albert T, Gupta Vishali et al.

This study found the dexamethasone implant was most effective for uveitic macular edema over 24 weeks compared to ranibizumab or methotrexate, offering a superior treatment option despite side effects.

Acharya Nisha R, Vitale Albert T, Sugar Elizabeth A, Holbrook Janet T, Burke Alyce E, Thorne Jennifer E et al.

The MERIT trial found dexamethasone implants are superior to methotrexate and ranibizumab for uveitic macular edema at 12 weeks, despite a higher risk of treatable IOP elevation.

Böni Christian, Thorne Jennifer E, Spaide Richard F, Ostheimer Trucian A, Sarraf David, Levinson Ralph D et al.

This study found common fundus autofluorescence (FAF) abnormalities, especially hypoautofluorescence, in birdshot chorioretinitis patients. These FAF changes indicate retinal pigment epithelium dysfunction and correlate with worse vision.

DellaCroce John T, Vitale Albert T

Hypertension causes diverse eye changes (retinopathy, glaucoma risk). Fundoscopic screening for these microvascular changes offers crucial prognostic data for cardiovascular risk and disease management.